Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 May;3(5-6):414-25.
doi: 10.1177/1947601912458586.

Activation of abl family kinases in solid tumors

Affiliations

Activation of abl family kinases in solid tumors

Sourik S Ganguly et al. Genes Cancer. 2012 May.

Abstract

Although c-Abl and Arg non-receptor tyrosine kinases are well known for driving leukemia development, their role in solid tumors has not been appreciated until recently. Accumulating evidence now indicates that c-Abl and/or Arg are activated in some solid tumor cell lines via unique mechanisms that do not involve gene mutation/translocation, and c-Abl/Arg activation promotes matrix degradation, invasion, proliferation, tumorigenesis, and/or metastasis, depending on the tumor type. However, some data suggest that c-Abl also may suppress invasion, proliferation, and tumorigenesis in certain cell contexts. Thus, c-Abl/Arg may serve as molecular switches that suppress proliferation and invasion in response to some stimuli (e.g., ephrins) or when inactive/regulated, or as promote invasion and proliferation in response to other signals (e.g., activated growth factor receptors, loss of inhibitor expression), which induce sustained activation. Clearly, more data are required to determine the extent and prevalence of c-Abl/Arg activation in primary tumors and during progression, and additional animal studies are needed to substantiate in vitro findings. Furthermore, c-Abl/Arg inhibitors have been used in numerous solid tumor clinical trials; however, none of these trials were restricted to patients whose tumors expressed highly activated c-Abl/Arg (targeted trial). Targeted trials are critical for determining whether c-Abl/Arg inhibitors can be effective treatment options for patients whose tumors are driven by c-Abl/Arg.

Keywords: Arg; c-Abl; solid tumor; tyrosine kinase.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: Dr. Plattner’s work is funded by the National Institutes of Health. The authors declare no other potential conflict of interest with respect to the authorship and/or publication of this article.

Figures

Figure 1.
Figure 1.
Activation of c-Abl/Arg in solid tumors. Summary of the signals that induce constitutive activation of cell surface receptors (receptor tyrosine kinases, claudin-1), in a variety of solid tumors, induces constitutive activation of c-Abl/Arg. c-Abl/Arg, in-turn, activate a variety of intracellular signaling pathways, which result in increased survival, proliferation, anchorage-independent growth, migration, matrix degradation, and invasion, processes necessary for tumor growth and/or metastatic progression. Arrow colors indicate proteins that are in the same signaling pathways.

References

    1. Koleske AJ, Gifford AM, Scott ML, et al. Essential roles for the Abl and Arg tyrosine kinases in neurulation. Neuron. 1998;21:1259-72 - PubMed
    1. Colicelli J. ABL tyrosine kinases: evolution of function, regulation, and specificity. Sci Signal. 2010;3:re6. - PMC - PubMed
    1. Hantschel O, Nagar B, Guettler S, Kretzschmar J, Dorey K, Superti-Furga G. A myristoyl/phosphotyrosine switch regulates c-Abl. Cell. 2003;112:845-57 - PubMed
    1. Pluk H, Dorey K, Superti-Furga G. Autoinhibition of c-Abl. Cell. 2002;108:247-59 - PubMed
    1. Zhu J, Shore SK. c-ABL tyrosine kinase activity is regulated by association with a novel SH3-domain-binding protein. Mol Cell Biol. 1996;16:7054-62 - PMC - PubMed

LinkOut - more resources